These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 29898989)
1. Disruption of a -35 kb Enhancer Impairs CTCF Binding and Liu Q; Thoms JAI; Nunez AC; Huang Y; Knezevic K; Packham D; Poulos RC; Williams R; Beck D; Hawkins NJ; Ward RL; Wong JWH; Hesson LB; Sloane MA; Pimanda JE Clin Cancer Res; 2018 Sep; 24(18):4602-4611. PubMed ID: 29898989 [No Abstract] [Full Text] [Related]
2. Comprehensive analysis of the Morak M; Ibisler A; Keller G; Jessen E; Laner A; Gonzales-Fassrainer D; Locher M; Massdorf T; Nissen AM; Benet-Pagès A; Holinski-Feder E J Med Genet; 2018 Apr; 55(4):240-248. PubMed ID: 29472279 [TBL] [Abstract][Full Text] [Related]
3. Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients. Jansen AM; Geilenkirchen MA; van Wezel T; Jagmohan-Changur SC; Ruano D; van der Klift HM; van den Akker BE; Laros JF; van Galen M; Wagner A; Letteboer TG; Gómez-García EB; Tops CM; Vasen HF; Devilee P; Hes FJ; Morreau H; Wijnen JT PLoS One; 2016; 11(6):e0157381. PubMed ID: 27300758 [TBL] [Abstract][Full Text] [Related]
4. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy. Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579 [TBL] [Abstract][Full Text] [Related]
5. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome. Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668 [TBL] [Abstract][Full Text] [Related]
6. Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation. Hitchins MP Fam Cancer; 2016 Jul; 15(3):413-22. PubMed ID: 26886015 [TBL] [Abstract][Full Text] [Related]
7. Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family. Cini G; Carnevali I; Quaia M; Chiaravalli AM; Sala P; Giacomini E; Maestro R; Tibiletti MG; Viel A Carcinogenesis; 2015 Apr; 36(4):452-8. PubMed ID: 25742745 [TBL] [Abstract][Full Text] [Related]
8. Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort. Rosty C; Clendenning M; Walsh MD; Eriksen SV; Southey MC; Winship IM; Macrae FA; Boussioutas A; Poplawski NK; Parry S; Arnold J; Young JP; Casey G; Haile RW; Gallinger S; Le Marchand L; Newcomb PA; Potter JD; DeRycke M; Lindor NM; Thibodeau SN; Baron JA; Win AK; Hopper JL; Jenkins MA; Buchanan DD; BMJ Open; 2016 Feb; 6(2):e010293. PubMed ID: 26895986 [TBL] [Abstract][Full Text] [Related]
9. Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses. Haraldsdottir S; Hampel H; Wu C; Weng DY; Shields PG; Frankel WL; Pan X; de la Chapelle A; Goldberg RM; Bekaii-Saab T Genet Med; 2016 Sep; 18(9):863-8. PubMed ID: 26866578 [TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency. Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842 [TBL] [Abstract][Full Text] [Related]
12. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients. Alemayehu A; Sebova K; Fridrichova I Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713 [TBL] [Abstract][Full Text] [Related]
13. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population. Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186 [TBL] [Abstract][Full Text] [Related]
14. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Niessen RC; Hofstra RM; Westers H; Ligtenberg MJ; Kooi K; Jager PO; de Groote ML; Dijkhuizen T; Olderode-Berends MJ; Hollema H; Kleibeuker JH; Sijmons RH Genes Chromosomes Cancer; 2009 Aug; 48(8):737-44. PubMed ID: 19455606 [TBL] [Abstract][Full Text] [Related]
15. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. Mensenkamp AR; Vogelaar IP; van Zelst-Stams WA; Goossens M; Ouchene H; Hendriks-Cornelissen SJ; Kwint MP; Hoogerbrugge N; Nagtegaal ID; Ligtenberg MJ Gastroenterology; 2014 Mar; 146(3):643-646.e8. PubMed ID: 24333619 [TBL] [Abstract][Full Text] [Related]
16. MLH1 epimutation is a rare mechanism for Lynch syndrome: A case report and review of the literature. Zyla R; Graham T; Aronson M; Velsher L; Mrkonjic M; Turashvili G Genes Chromosomes Cancer; 2021 Sep; 60(9):635-639. PubMed ID: 33934415 [TBL] [Abstract][Full Text] [Related]
17. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526 [TBL] [Abstract][Full Text] [Related]
18. Tumor buds show reduced expression of laminin-5 gamma 2 chain in DNA mismatch repair deficient colorectal cancer. Shinto E; Baker K; Tsuda H; Mochizuki H; Ueno H; Matsubara O; Foulkes WD; Jass JR Dis Colon Rectum; 2006 Aug; 49(8):1193-202. PubMed ID: 16773493 [TBL] [Abstract][Full Text] [Related]